| 17th Oct 2019 3:53 pm |
RNS |
Holdings in Company |
| 16th Oct 2019 7:30 am |
RNS |
Holding(s) in Company |
| 30th Sep 2019 7:00 am |
RNS |
Half-year Report |
| 27th Sep 2019 7:00 am |
RNS |
Phase II Biomarker Data for SNG001 to be presented |
| 24th Jul 2019 7:00 am |
RNS |
Phase II Clinical Trial Update |
| 8th Jul 2019 5:48 pm |
RNS |
Holdings in Company |
| 3rd Jun 2019 11:52 am |
RNS |
Result of AGM |
| 18th Apr 2019 9:20 am |
RNS |
Directorate Change, Annual Report & Notice of AGM |
| 5th Apr 2019 12:55 pm |
RNS |
Grant of Options |
| 14th Mar 2019 7:00 am |
RNS |
Positive DSMC Review of Phase II Study for SNG001 |
| 25th Feb 2019 7:00 am |
RNS |
Preliminary results for the year ended 31 Dec 2018 |
| 17th Jan 2019 8:31 am |
RNS |
Update on LOXL2 programme with Pharmaxis |
| 22nd Oct 2018 10:05 am |
RNS |
Holding(s) in Company |
| 22nd Oct 2018 7:00 am |
RNS |
Part 2 start of Phase II COPD trial |
| 16th Oct 2018 3:01 pm |
RNS |
Holding(s) in Company |
| 15th Oct 2018 8:49 am |
RNS |
Holding(s) in Company |
| 12th Oct 2018 11:05 am |
RNS |
Result of General Meeting |
| 12th Oct 2018 10:29 am |
RNS |
Result of General Meeting |
| 25th Sep 2018 5:56 pm |
RNS |
Result of Fundraise |
| 25th Sep 2018 1:01 pm |
RNS |
Proposed Fundraise to raise c.£2.9 million |
| 25th Sep 2018 1:00 pm |
RNS |
Half-year Report |
| 28th Jun 2018 7:00 am |
RNS |
Positive SNG001 Biomarker Data in COPD Patients |
| 26th Jun 2018 1:05 pm |
RNS |
Holding(s) in Company |
| 22nd Jun 2018 11:42 am |
RNS |
Result of AGM |
| 22nd Jun 2018 7:00 am |
RNS |
Synairgen Safety Data with SNG001 in COPD Patients |
| 17th May 2018 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 16th Apr 2018 4:29 pm |
RNS |
Holding(s) in Company |
| 6th Apr 2018 12:14 pm |
RNS |
Grant of Options |
| 3rd Apr 2018 5:21 pm |
RNS |
Holding(s) in Company |
| 15th Mar 2018 3:13 pm |
RNS |
Issue of Equity |
| 15th Mar 2018 3:11 pm |
RNS |
Holding(s) in Company |
| 15th Mar 2018 7:00 am |
RNS |
Preliminary results for year ended 31 Dec 2017 |
| 7th Feb 2018 7:00 am |
RNS |
Synairgen starts dosing in Phase II COPD study |
| 14th Dec 2017 7:00 am |
RNS |
Update on LOXL2 Programme&Pharmaxis Collaboration |
| 8th Nov 2017 4:31 pm |
RNS |
Holding(s) in Company |
| 27th Sep 2017 7:00 am |
RNS |
Interim results for six months ended 30 June 2017 |
| 27th Sep 2017 7:00 am |
RNS |
Data update and clinical plan for COPD |
| 13th Sep 2017 12:44 pm |
RNS |
Holding(s) in Company |
| 6th Sep 2017 7:00 am |
RNS |
LOXL2 Inhibitor Update. |
| 28th Jun 2017 12:41 pm |
RNS |
Result of AGM |
